Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study

被引:1
|
作者
Subramanian, Lalita [1 ]
Hawley, Sarah T. [1 ,2 ]
Skolarus, Ted A. [2 ,3 ]
Rankin, Aaron [1 ]
Fetters, Michael D. [4 ]
Witzke, Karla [5 ]
Chen, Jason [1 ]
Radhakrishnan, Archana [1 ,2 ,6 ]
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] VA Ann Arbor Healthcare Syst, Ctr Clin Management Res, Hlth Serv Res & Dev, Ann Arbor, MI USA
[3] Univ Chicago, Dept Surg, Urol Sect, Chicago, IL USA
[4] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA
[5] MyMichigan Hlth, Dept Urol, Midland, MI USA
[6] Univ Michigan, Dept Internal Med, Div Gen Med, Internal Med, Ann Arbor, MI 48109 USA
来源
CANCER MEDICINE | 2024年 / 13卷 / 01期
关键词
active surveillance; primary care physicians; prostate cancer; quality of life; trust; urologists; MEN; CRITERIA;
D O I
10.1002/cam4.6847
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundProstate cancer is the most common cancer among men in the United States. Treatment guidelines recommend active surveillance for low-risk prostate cancer, which involves monitoring for progression, to avoid or delay definitive treatments and their side effects. Despite increased uptake, adherence to surveillance remains a challenge.MethodsWe conducted semi-structured, qualitative, virtual interviews based on the Theoretical Domains Framework (TDF), with men (15) who were or had been on active surveillance for their low-risk prostate cancer in 2020. Interviews were transcribed and coded under TDF's behavioral theory-based domains. We analyzed domains related to adherence to surveillance using constructivist grounded theory to identify themes influencing decision processes in adherence.ResultsThe TDF domains of emotion, beliefs about consequences, environmental context and resources, and social influences were most relevant to surveillance adherence-. From these four TDF domains, three themes emerged as underlying decision processes: trust in surveillance as treatment, quality of life, and experiences of self and others. Positive perceptions of these three themes supported adherence while negative perceptions contributed to non-adherence (i.e., not receiving follow-up or stopping surveillance). The relationship between the TDF domains and themes provided a theoretical process describing factors impacting active surveillance adherence for men with low-risk prostate cancer.ConclusionsMen identified key factors impacting active surveillance adherence that provide opportunities for clinical implementation and practice improvement. Future efforts should focus on multi-level interventions that foster trust in surveillance as treatment, emphasize quality of life benefits and enhance patients' interpersonal experiences while on surveillance to optimize adherence. Decision processes related to staying on or stopping active surveillance for prostate cancer involved trust in active surveillance as treatment, quality of life and experiences of self and others. Positive perceptions of these three themes supported adherence while negative perceptions contributed to non-adherence.image
引用
收藏
页数:11
相关论文
共 50 条
  • [41] THE QUALITY OF ACTIVE SURVEILLANCE FOR MEN WITH LOW-RISK PROSTATE CANCER
    Levy, Mya E.
    Meyers, Stephanie
    Wood, David P.
    Montie, James E.
    Miller, David C.
    Wei, John T.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 179 - 179
  • [42] Active surveillance beats surgery in low-risk prostate cancer
    Brower, Vicki
    LANCET ONCOLOGY, 2012, 13 (11): : E468 - E468
  • [43] Active Surveillance for Low-risk Prostate Cancer: Developments to Date
    Bangma, Chris H.
    Valdagni, Riccardo
    Carroll, Peter R.
    van Poppel, Hein
    Klotz, Laurence
    Hugosson, Jonas
    EUROPEAN UROLOGY, 2015, 67 (04) : 646 - 648
  • [44] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Katsuyoshi Hashine
    Hiroyuki Iio
    Yoshiteru Ueno
    Shohei Tsukimori
    Iku Ninomiya
    International Journal of Clinical Oncology, 2014, 19 : 531 - 535
  • [45] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Hashine, Katsuyoshi
    Iio, Hiroyuki
    Ueno, Yoshiteru
    Tsukimori, Shohei
    Ninomiya, Iku
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 531 - 535
  • [46] Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer
    Radhakrishnan, Archana
    Subramanian, Lalita
    Rankin, Aaron J.
    Fetters, Michael D.
    Wittmann, Daniela A.
    Ginsburg, Kevin B.
    Hawley, Sarah T.
    Skolarus, Ted A.
    ANNALS OF FAMILY MEDICINE, 2024, 22 (01) : 5 - 11
  • [47] Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative
    Kalapara, Arveen A.
    Verbeek, Jan F. M.
    Nieboer, Daan
    Fahey, Michael
    Gnanapragasam, Vincent
    Van Hemelrijck, Mieke
    Lee, Lui Shiong
    Bangma, Chris H.
    Steyerberg, Ewout W.
    Harkin, Tim
    Helleman, Jozien
    Roobol, Monique J.
    Frydenberg, Mark
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (01): : 80 - 91
  • [48] Determinants of urologists' adherence to active surveillance follow-up protocol for low-risk prostate cancer
    Hwang, Soohyun
    Birken, Sarah A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [49] Selecting Active Surveillance: Decision-Making Factors for Men with a Low-Risk Prostate Cancer
    Hoffman, Richard M.
    Lobo, Tania
    Van Den Eeden, Stephen K.
    Davis, Kimberly M.
    Luta, George
    Leimpeter, Amethyst D.
    Aaronson, David
    Penson, David F.
    Taylor, Kathryn
    MEDICAL DECISION MAKING, 2019, 39 (08) : 962 - 974
  • [50] SELECTING ACTIVE SURVEILLANCE: DECISION-MAKING FACTORS FOR MEN WITH A LOW-RISK PROSTATE CANCER
    Hoffman, Richard M.
    Lobo, Tania
    Van den Eeden, Stephen K.
    Luta, George
    Davis, Kimberly M.
    Aaronsen, David
    Taylor, Kathryn L.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S336 - S336